He began his career in the Mergers & Acquisitions Group at Drexel Burnham Lambert. Ken was also a founder of the high yield finance business at Chase Securities (now JP Morgan Chase). Prior to that he founded and was President and CEO of Churchill Financial Group, served as Head of Leveraged Finance for Royal Bank of Canada and was Head of Indosuez Capital, a leading middle market merchant banking and asset management business in partnership with Credit Agricole Group. (Carlyle’s publicly traded business development company). Previously, Ken served as a Managing Director of The Carlyle Group, where he also served as President and a Director of TCG BDC, Inc. Throughout his over 35-year career in the investment industry, he has accrued a broad range of experience in leading private credit investment businesses. He also serves as Chairman of the Board, President and CEO of Nuveen Churchill Direct Lending, Inc., Churchill’s publicly registered business development company. From 1975 to 1978 (3 years) Chief Scientific Officer Aerogen Pharma Corp.Ken serves as President and CEO of Churchill Asset Management, an affiliate of Nuveen, the asset management arm of TIAA, a Fortune 100 financial services company.
From June 1979 to January 1993 (13 years 8 months) Instructor Miami Dade College Teaching curriculum for the Associate Degree level Respiratory Care Program and EMT program. Arzu Ari and the Respiratory Therapy faculty to develop the aerosol science research program at Georgia State into a internationally recognized center of excellence From March 2009 to March 2017 (8 years 1 month) Research Associate Loyola University Chicago Developed Aerosol Lab to research best methods for clinical delivery of medical aerosols From May 1993 to April 2000 (7 years) Technical Director Respiratory Care University of California, San Francisco Administrative responsibility for clinical respiratory care services at Moffit/Long and Mt. From January 2009 to May 2016 (7 years 5 months) Adjunct Professor Georgia State University Working with Dr.
Provide clinical input and oversight in support of Regulatory, Quality, R and D, Product Development and BD. From April 2000 to October 2008 (8 years 7 months) Chief Clinical Officer Aerogen Pharma Corp. Developed systems for aerosol delivery by nasal CPAP to infants as well as inhaled vaccine delivery system for use in the third world. Invented applications for high efficiency aerosol delivery during mechanical ventilation to adults and infants. Fellow Pulmonary Research Nektar Therapeutics Came to Nektar with the Aerogen acquisition in 2005. From June 1993 to April 2000 (6 years 11 months) Adjunct Faculty, Respiratory Therapy Rush University Medical Center Developed and aerosol measurement laboratory and work with graduate students to develop and perform in vitro aerosol studies. From November 2008 to September 2015 (6 years 11 months) Senior Fellow Aerosol Science and Product Development Dance Biopharm Responsible aerosol science and product development San FranciscoFellow Aerogen From April 2000 to October 2005 (5 years 7 months) Mountain View, CAAdministrative Analyst Hines VA Medical Center Responsible for supporting clinical operations and labs for the Medical Service. Fink, LLC Providing consultation to the biotech industry, offering innovative approaches to device and drug device development.
0 kommentar(er)
